63 related articles for article (PubMed ID: 11134205)
1. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
Hayman JA; Martel MK; Ten Haken RK; Normolle DP; Todd RF; Littles JF; Sullivan MA; Possert PW; Turrisi AT; Lichter AS
J Clin Oncol; 2001 Jan; 19(1):127-36. PubMed ID: 11134205
[TBL] [Abstract][Full Text] [Related]
2. Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer.
Bertolini M; Trojani V; Botti A; Cucurachi N; Galaverni M; Cozzi S; Borghetti P; La Mattina S; Pastorello E; Avanzo M; Revelant A; Sepulcri M; Paronetto C; Ursino S; Malfatti G; Giaj-Levra N; Falcinelli L; Iotti C; Iori M; Ciammella P
Curr Oncol; 2022 Jul; 29(8):5179-5194. PubMed ID: 35892979
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience.
Katz LM; Ng V; Wu SP; Yan S; Grew D; Shin S; Colangelo NW; McCarthy A; Pass HI; Chachoua A; Schiff PB
Front Oncol; 2022; 12():870143. PubMed ID: 35686111
[TBL] [Abstract][Full Text] [Related]
4. Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Lee P; Loo BW; Biswas T; Ding GX; El Naqa IM; Jackson A; Kong FM; LaCouture T; Miften M; Solberg T; Tome WA; Tai A; Yorke E; Li XA
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):160-171. PubMed ID: 30954520
[TBL] [Abstract][Full Text] [Related]
5. Normal lung sparing Tomotherapy technique in stage III lung cancer.
Hong CS; Ju SG; Ahn YC; Yoo GS; Noh JM; Oh D; Chung K; Pyo H; Jo K
Radiat Oncol; 2017 Nov; 12(1):167. PubMed ID: 29110732
[TBL] [Abstract][Full Text] [Related]
6. Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging.
Matuszak MM; Matrosic C; Jarema D; McShan DL; Stenmark MH; Owen D; Jolly S; Kong FS; Ten Haken RK
Adv Radiat Oncol; 2016; 1(4):281-289. PubMed ID: 28740898
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: a 6-field technique using lateral beams in conformal radiotherapy for bilateral supraclavicular lymph node metastases.
Tsutsumi S; Tada T; Maekado T; Tokunaga M; Tanaka N; Kobayashi A; Okazaki E; Matsuda S; Hosono MN; Miki Y
Springerplus; 2014; 3():733. PubMed ID: 25674465
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
[TBL] [Abstract][Full Text] [Related]
9. Evidence based radiation oncology with existing technology.
Isa N
Rep Pract Oncol Radiother; 2014 Jul; 19(4):259-66. PubMed ID: 25061519
[TBL] [Abstract][Full Text] [Related]
10. Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.
Scorsetti M; Navarria P; De Rose F; Ascolese A; Clerici E; Franzese C; Lobefalo F; Reggiori G; Mancosu P; Tomatis S; Fogliata A; Cozzi L
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1937-45. PubMed ID: 24934724
[TBL] [Abstract][Full Text] [Related]
11. High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study.
Oshiro Y; Okumura T; Kurishima K; Homma S; Mizumoto M; Ishikawa H; Onizuka M; Sakai M; Goto Y; Hizawa N; Sato Y; Sakurai H
J Radiat Res; 2014 Sep; 55(5):959-65. PubMed ID: 24864278
[TBL] [Abstract][Full Text] [Related]
12. Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.
Glide-Hurst CK; Chetty IJ
J Thorac Dis; 2014 Apr; 6(4):303-18. PubMed ID: 24688775
[TBL] [Abstract][Full Text] [Related]
13. Pattern of failure after high-dose thoracic radiation for non-small cell lung cancer: the University of Michigan experience.
Hunter KU; Kong FM; Chetty IJ; Cronin P; Tatro D; Marn C; Hayman JA; Ten Haken RK
J Radiat Oncol; 2012 Sep; 1(3):267-272. PubMed ID: 24575170
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.
Boda-Heggemann J; Frauenfeld A; Weiss C; Simeonova A; Neumaier C; Siebenlist K; Attenberger U; Heußel CP; Schneider F; Wenz F; Lohr F
Radiat Oncol; 2014 Jan; 9():10. PubMed ID: 24401323
[TBL] [Abstract][Full Text] [Related]
15. Involved-field radiotherapy versus elective nodal irradiation in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer: a prospective randomized study.
Chen M; Bao Y; Ma HL; Hu X; Wang J; Wang Y; Peng F; Zhou QC; Xie CH
Biomed Res Int; 2013; 2013():371819. PubMed ID: 23762840
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer.
Hepel JT; Peter J; Hiatt JR; Patel S; Osibanjo O; Safran H; Curran B; Dipetrillo T
Front Oncol; 2012; 2():124. PubMed ID: 23057009
[TBL] [Abstract][Full Text] [Related]
17. Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis.
Song C; Pyo H; Kim J; Lim YK; Kim WC; Kim HJ; Kim DW; Cho KH
Strahlenther Onkol; 2012 Oct; 188(10):901-9. PubMed ID: 22895625
[TBL] [Abstract][Full Text] [Related]
18. The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancer.
Spych M; Gottwald L; Klonowicz M; Biegała M; Bibik R; Fijuth J
Arch Med Sci; 2010 Oct; 6(5):756-63. PubMed ID: 22419936
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer.
Schuette W; Krzakowski MJ; Massuti B; Otterson GA; Lizambri R; Wei H; Berger DP; Chen Y
J Thorac Oncol; 2012 Jan; 7(1):157-64. PubMed ID: 22011667
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy in clinical practice.
Liu H; Chang JY
Chin J Cancer; 2011 May; 30(5):315-26. PubMed ID: 21527064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
